Economic Evidence on Biliary Tract Cancer: A Systematic Review
João Rocha-Gomes, Ana Sofia Teixeira, Marina Ruiz-Romeo, José Manuel Oliveira, Patrícia Ramos · 2026
Read Economic Evidence on Biliary Tract Cancer: A Systematic Review by João Rocha-Gomes, Ana Sofia Teixeira, Marina Ruiz-Romeo, José Manuel Oliveira, Patrícia Ramos (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13360021.txt.
Description
João Rocha-Gomes and co-authors review the economics of a harsh cancer group in a 2026 paper. Biliary tract cancers are uncommon, aggressive, and usually found late. New immune and targeted drugs have widened choices but raised costs. The team gathered the published economic evidence: studies of value for money, illness costs, and resource use.
Twenty studies qualified. Older chemotherapy plans looked better value in several settings, while most immune combinations and targeted drugs exceeded local value thresholds at current prices. Real-world care proved heavy on hospitals, above all in later treatment lines. Evidence on prevention and screening was thin, the review notes.
Catalog record
| CREATOR | João Rocha-Gomes, Ana Sofia Teixeira, Marina Ruiz-Romeo, José Manuel Oliveira, Patrícia Ramos |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41047 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |